Eureka Therapeutics Secures $6,000,000 Series B Financing

  • Feed Type
  • Date
    11/17/2008
  • Company Name
    Eureka Therapeutics
  • Mailing Address
    5858 Horton Street Emeryville, CA 94608
  • Company Description
    Eureka Therapeutics, Inc. is a privately-owned, venture capital-funded biotechnology company headquartered in Emeryville, California. Eureka provides a range of services and products to partner companies pursuing therapeutic antibody treatments for disease.

    Our primary technology involves the enhancement of the ADCC activity of human (or humanized) antibodies to improve their clinical efficacy. Currently, Eureka has one US research facility dedicated to technology innovation and service provision, and one Chinese subsidiary in Beijing for carrying.

  • Website
    http://www.eurekainc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy